Nonalcoholic Steatohepatitis Enrolling by Invitation Phase 4 Trials for Raltegravir (DB06817)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02210715Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected PatientsScreening